Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-25

Clinical Trial Update: Hypofractionated Radiotherapy Plus Temozolamide in Patients Younger Than 70 Years With Glioblastoma [NA]

View source ↗

Summary

A clinical trial is evaluating hypofractionated radiotherapy plus temozolomide in patients younger than 70 with glioblastoma. The study status is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temodar (Temozolomide)

Snippet

Sponsor: Hospital do Coracao | Conditions: Glioblastoma (GBM) | NA | Status: NOT_YET_RECRUITING